{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Mississauga",
      "state": "",
      "country": "Canada",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "94066",
      "recalling_firm": "Contract Pharmaceuticals Limited Canada",
      "address_1": "7600 East Danbro Cres",
      "address_2": "",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the U.S. and Puerto Rico",
      "recall_number": "D-0364-2024",
      "product_description": "Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61",
      "product_quantity": "45,875 bottles",
      "reason_for_recall": "Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.",
      "recall_initiation_date": "20240220",
      "center_classification_date": "20240301",
      "report_date": "20240313",
      "code_info": "Lot #: 119466, 119467 Exp 04/2025; 120351 Exp 08/2025; 121712 Exp 11/2025",
      "more_code_info": ""
    }
  ]
}